| Datum | Zeit | Quelle | Überschrift | Symbol | Firma |
| 14/02/2019 | 12h43 | Edgar (US Regulatory) | Amended Statement of Ownership (sc 13g/a) | NASDAQ:JUNO | Juno Therapeutics, Inc. (delisted) |
| 16/04/2018 | 22h08 | Edgar (US Regulatory) | Confidential Treatment Order (ct Order) | NASDAQ:JUNO | Juno Therapeutics, Inc. (delisted) |
| 16/03/2018 | 13h02 | Edgar (US Regulatory) | Termination of Registration of a Class of Security Under Section 12(b) (15-12b) | NASDAQ:JUNO | Juno Therapeutics, Inc. (delisted) |
| 09/03/2018 | 16h52 | Edgar (US Regulatory) | Amended Statement of Ownership (sc 13g/a) | NASDAQ:JUNO | Juno Therapeutics, Inc. (delisted) |
| 08/03/2018 | 00h26 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:JUNO | Juno Therapeutics, Inc. (delisted) |
| 08/03/2018 | 00h25 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:JUNO | Juno Therapeutics, Inc. (delisted) |
| 08/03/2018 | 00h25 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:JUNO | Juno Therapeutics, Inc. (delisted) |
| 08/03/2018 | 00h24 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:JUNO | Juno Therapeutics, Inc. (delisted) |
| 08/03/2018 | 00h23 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:JUNO | Juno Therapeutics, Inc. (delisted) |
| 08/03/2018 | 00h22 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:JUNO | Juno Therapeutics, Inc. (delisted) |
| 08/03/2018 | 00h21 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:JUNO | Juno Therapeutics, Inc. (delisted) |
| 08/03/2018 | 00h19 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:JUNO | Juno Therapeutics, Inc. (delisted) |
| 08/03/2018 | 00h18 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:JUNO | Juno Therapeutics, Inc. (delisted) |
| 08/03/2018 | 00h17 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:JUNO | Juno Therapeutics, Inc. (delisted) |
| 08/03/2018 | 00h16 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:JUNO | Juno Therapeutics, Inc. (delisted) |
| 08/03/2018 | 00h15 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:JUNO | Juno Therapeutics, Inc. (delisted) |
| 08/03/2018 | 00h14 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:JUNO | Juno Therapeutics, Inc. (delisted) |
| 08/03/2018 | 00h13 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:JUNO | Juno Therapeutics, Inc. (delisted) |
| 06/03/2018 | 14h33 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:JUNO | Juno Therapeutics, Inc. (delisted) |
| 06/03/2018 | 14h30 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:JUNO | Juno Therapeutics, Inc. (delisted) |
| 06/03/2018 | 14h28 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:JUNO | Juno Therapeutics, Inc. (delisted) |
| 06/03/2018 | 14h26 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:JUNO | Juno Therapeutics, Inc. (delisted) |
| 06/03/2018 | 14h24 | Edgar (US Regulatory) | (25-NSE) | NASDAQ:JUNO | Juno Therapeutics, Inc. (delisted) |
| 06/03/2018 | 14h13 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:JUNO | Juno Therapeutics, Inc. (delisted) |
| 06/03/2018 | 14h02 | Edgar (US Regulatory) | Initial Statement of Beneficial Ownership (3) | NASDAQ:JUNO | Juno Therapeutics, Inc. (delisted) |
| 05/03/2018 | 14h19 | Edgar (US Regulatory) | Amended Statement of Ownership: Private Transaction (sc 13e3/a) | NASDAQ:JUNO | Juno Therapeutics, Inc. (delisted) |
| 05/03/2018 | 14h13 | Edgar (US Regulatory) | Amended Statement of Ownership: Solicitation (sc 14d9/a) | NASDAQ:JUNO | Juno Therapeutics, Inc. (delisted) |
| 05/03/2018 | 14h03 | Edgar (US Regulatory) | Amended Statement of Beneficial Ownership (sc 13d/a) | NASDAQ:JUNO | Juno Therapeutics, Inc. (delisted) |
| 05/03/2018 | 14h02 | Edgar (US Regulatory) | Amended Statement of Ownership: Private Transaction (sc 13e3/a) | NASDAQ:JUNO | Juno Therapeutics, Inc. (delisted) |
| 05/03/2018 | 14h02 | Edgar (US Regulatory) | Amended Tender Offer Statement by Third Party (sc To-t/a) | NASDAQ:JUNO | Juno Therapeutics, Inc. (delisted) |